Core Insights - The company, Cuohua Co., reported that as of September 30, 2025, the total number of shareholders is 11,554 [2] Summary by Category - **Company Information** - Cuohua Co. disclosed its shareholder count in response to investor inquiries on November 20 [2] - The total number of shareholders is 11,554 as per the company's third-quarter report [2] - **Industry Context** - No specific industry context or additional insights were provided in the news article [2]

11月19日，醋化股份盘中下跌2.15%，截至10:46，报12.28元/股，成交1447.41万元，换手率0.57%，总 市值25.11亿元。 醋化股份今年以来股价涨32.47%，近5个交易日跌2.54%，近20日涨0.00%，近60日跌5.10%。 资料显示，南通醋酸化工股份有限公司位于江苏省南通经济技术开发区江山路968号，成立日期，上市 日期2015年5月18日，公司主营业务涉及从事以醋酸衍生物、吡啶衍生物为主体的高端专用精细化学品 的研发、生产和销售。主营业务收入构成为：食品饲料添加剂28.53%，医药农药中间体20.29%，农化 类17.09%，其他商品12.51%，颜(染)料中间体11.97%，其他有机化合物7.19%，其他(补充)2.41%。 醋化股份所属申万行业为：基础化工-化学制品-食品及饲料添加剂。所属概念板块包括：微盘股、小 盘、代糖概念等。 截至9月30日，醋化股份股东户数1.16万，较上期减少13.79%；人均流通股17697股，较上期增加 15.99%。2025年1月-9月，醋化股份实现营业收入19.91亿元，同比减少9.44%；归母净利润-2423.02万 元，同比增长74.1 ...

Core Viewpoint - Vine Chemical Co., Ltd. (603968.SH) reported its Q3 2025 results, highlighting a total institutional ownership of 38.25 million shares, representing 18.71% of the total share capital, with a slight decline in institutional ownership compared to the previous quarter [1] Institutional Ownership - As of October 30, 2025, six institutional investors disclosed their holdings in Vine Chemical, with a combined ownership of 38.25 million shares, accounting for 18.71% of the total share capital [1] - The total institutional ownership decreased by 0.56 percentage points compared to the previous quarter [1] Public Fund Holdings - Two public funds increased their holdings compared to the previous period, namely Jianxin Flexible Allocation Mixed A and CITIC Securities CSI 1000 Index Enhanced A, with an increase in ownership proportion of 0.21% [1] - One new public fund disclosed its holdings this quarter, which is Su Xin Shanghai Stock Exchange Science and Technology Innovation Index Enhanced A [1] - A total of 48 public funds did not disclose their holdings this quarter, including notable funds such as Nuon An Multi-Strategy Mixed A and Morgan Stanley Multi-Factor Strategy Mixed A [1]

Core Viewpoint - Zihua Co., Ltd. is a significant player in the high-end specialty fine chemicals sector in China, focusing on acetic acid derivatives and pyridine derivatives, with a notable market and technical advantage in the fine chemical industry [1] Group 1: Business Performance - For Q3 2025, Zihua Co., Ltd. reported a revenue of 1.991 billion yuan, ranking 9th among 24 companies in the industry. The top company, Meihua Biological, had a revenue of 18.215 billion yuan, while the industry average was 3.571 billion yuan [2] - The company's net profit for the same period was -21.4158 million yuan, placing it last in the industry. The leading company, Xinheng, reported a net profit of 5.354 billion yuan, with the industry average at 539 million yuan [2] Group 2: Financial Ratios - As of Q3 2025, Zihua Co., Ltd. had a debt-to-asset ratio of 44.36%, which is higher than the previous year's 43.71% and above the industry average of 28.46%, indicating significant debt pressure [3] - The company's gross profit margin for Q3 2025 was 12.01%, an increase from 8.56% year-on-year, but still below the industry average of 28.77%, suggesting room for improvement in profitability [3] Group 3: Executive Compensation - The chairman, Qing Jiu, received a salary of 1.3589 million yuan in 2024, an increase of 224,900 yuan from 2023. The president, Yu Xinnan, had a salary of 1.2799 million yuan, up by 199,900 yuan from the previous year [4] Group 4: Shareholder Information - As of September 30, 2025, the number of A-share shareholders decreased by 13.79% to 11,600, while the average number of circulating A-shares held per account increased by 15.99% to 17,700 [5]

根据上海证券交易所《上市公司自律监管指引第 3 号行业信息披露：第十三 号——化工》、《关于做好主板上市公司 2025 年第三季度报告披露工作的重要提 醒》的要求，南通醋酸化工股份有限公司（以下简称"公司"）现将 2025 年三 季度主要经营数据披露如下： 注：其他有机化合物类产品乙烯酮均为自产自用，产品双乙烯酮大部分自产自用。 三、主要原材料的价格变动情况（含税） 证券代码：603968 证券简称：醋化股份 公告编号：临2025-036 南通醋酸化工股份有限公司 2025年三季度主要经营数据公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 | 主要原料 | 2024 年 1-9 月 | 2025 年 1-9 月 | 三季度同比 | 三季度环比变 | | --- | --- | --- | --- | --- | | | 平均进价（元/吨） | 平均进价（元/吨） | 变动比率（%） | 动比率（%） | | 冰醋酸 | 2,985.99 | 2,447.72 | -18.03 | -7.71 | | 巴豆醛 | 13,0 ...

南通醋酸化工股份有限公司 关于2025年前三季度计提资产减值准备的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 证券代码：603968 证券简称：醋化股份 公告编号：临2025-035 1、信用减值准备 根据企业会计准则规定，公司于资产负债表日对各项应收款项参考历史信用 损失经验，结合当前状况以及对未来经济状况的预测，通过违约风险敞口和未来 12 个月内或整个存续期预期信用损失率，计算预期信用损失。2025 年前三季度 对公司的应收账款、其他应收款计提信用减值准备，计提金额扣除收回或转回额 后的净额为-53.61 万元，应收款项核销 83.11 万元，期末坏账准备余额 2,295.66 万元。 2、存货跌价准备 本公司存货分为原材料、在产品、半成品、产成品、发出商品、低值易耗品、 委托加工物资等，资产负债表日，存货成本高于其可变现净值的，计提存货跌价 准备。公司期末对所有存货进行全面清查，并进行减值测试，按可变现净值低于 成本的差额计提存货跌价准备 4,600.66 万元，期末存货跌价准备余额 2,436.32 万元。 ...

证券代码：603968 证券简称：醋化股份 公告编号：临2025-034 南通醋酸化工股份有限公司 第八届董事会第二十三次会议决议的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者 重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 一、董事会会议召开情况 （一）审议并通过《南通醋酸化工股份有限公司2025年第三季度报告》 同意公司《2025年第三季度报告》。 具体内容详见上海证券交易所网站（www.sse.com.cn）。 经表决：赞成9票，反对0票，弃权0票。 该事项已经第八届董事会审计委员会2025年第四次会议审议通过，并提交董事 会审议。 （二）审议并通过《关于2025年前三季度计提减值准备的议案》 具体内容详见上海证券交易所网站（www.sse.com.cn）（公告临2025-035）。 经表决：赞成9票，反对0票，弃权0票。 南通醋酸化工股份有限公司（以下简称"公司"）第八届董事会第二十三次会 议于2025年10月29日以通讯表决的方式召开。本次会议通知于2025年10月26日以电 子邮件方式发出，应参与表决董事9人，实际参与表决董事9人。会议的召集和召开 程序 ...

Financial Performance - The company's operating revenue for the third quarter was ¥592,215,558.91, a decrease of 15.74% compared to the same period last year[4] - The total profit for the third quarter was -¥29,812,965.01, representing an increase of 42.44% year-on-year[4] - The net profit attributable to shareholders was -¥26,838,871.21, reflecting a 45.93% increase compared to the same quarter last year[4] - The net profit attributable to shareholders after deducting non-recurring gains and losses was -¥34,805,677.92, a decrease of 34.67% year-on-year[4] - The basic earnings per share for the third quarter was -¥0.1300, an increase of 45.54% compared to the same period last year[4] - Total operating revenue for the first three quarters of 2025 was RMB 1,991,274,646.75, a decrease of 9.45% compared to RMB 2,198,902,945.07 in the same period of 2024[18] - The net profit for the first three quarters of 2025 was -21,415,825.28 RMB, compared to -91,351,734.39 RMB in the same period of 2024, showing an improvement[19] - The company reported a total comprehensive loss of -21,648,048.11 RMB for the first three quarters of 2025, compared to -90,875,229.29 RMB in 2024[19] - The basic and diluted earnings per share for the first three quarters of 2025 were both -0.1174 RMB, an improvement from -0.4503 RMB in 2024[19] Assets and Liabilities - The total assets at the end of the reporting period were ¥3,412,557,179.21, an increase of 1.68% from the end of the previous year[5] - Total assets as of September 30, 2025, amounted to RMB 3,412,557,179.21, an increase from RMB 3,356,330,821.20 at the end of 2024[16] - Total liabilities as of September 30, 2025, were RMB 1,513,863,346.68, compared to RMB 1,438,950,953.60 at the end of 2024, reflecting an increase of 5.2%[15] - The company's equity attributable to shareholders was RMB 1,805,945,809.76 as of September 30, 2025, down from RMB 1,825,205,300.81 at the end of 2024[16] Cash Flow - The net cash flow from operating activities for the year-to-date was -¥123,572,668.05, a decrease of 403.86% compared to the same period last year[4] - Operating cash flow for the first three quarters of 2025 was -123,572,668.05 RMB, a decline from -24,525,152.38 RMB in 2024[21] - Cash and cash equivalents as of September 30, 2025, were RMB 339,878,449.86, a decrease from RMB 658,162,888.55 at the end of 2024[13] - The cash and cash equivalents at the end of the period were 324,054,571.21 RMB, down from 456,160,441.44 RMB at the end of the same period in 2024[22] - The net cash flow from investing activities for the first three quarters of 2025 was -326,134,696.41 RMB, an improvement from -414,466,502.31 RMB in 2024[22] Operating Costs and Expenses - Total operating costs for the first three quarters of 2025 were RMB 1,985,006,859.22, down 11.58% from RMB 2,244,815,413.87 in the previous year[18] - Operating costs included RMB 1,752,043,398.69 for cost of goods sold, which decreased from RMB 2,010,765,649.25 in 2024, indicating a reduction of 13.0%[18] - The company incurred a total operating expense of 1,786,725,003.70 RMB in 2025, slightly lower than 1,791,219,170.68 RMB in 2024[21] Research and Development - Research and development expenses for the first three quarters of 2025 were RMB 67,148,435.29, slightly down from RMB 67,239,395.73 in 2024[18] Borrowings and Financing - The company reported a significant increase in short-term borrowings, rising to RMB 273,000,000.00 from RMB 97,000,000.00 in the previous period[14] - The company received cash from borrowings amounting to 632,932,853.04 RMB in 2025, compared to 547,064,682.03 RMB in 2024, reflecting an increase of approximately 15.7%[22] Non-Recurring Gains - The company reported non-recurring gains of ¥7,966,806.71 for the third quarter, with government subsidies contributing ¥3,454,396.25[7] - The company reported a decrease in other comprehensive income attributable to the parent company, with a net amount of -411,969.10 RMB in 2025 compared to 240,764.10 RMB in 2024[19] Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 11,554[10] - The weighted average return on net assets was -1.47%, an increase of 1.12 percentage points compared to the previous year[4]

证券代码：603968 证券简称：醋化股份 公告编号：临2025-033 南通醋酸化工股份有限公司 关于召开2025年半年度业绩说明会的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 南通醋酸化工股份有限公司（以下简称"公司"）已于 2025 年 8 月 29 日在 《中国证券报》、《上海证券报》、《证券日报》以及上海证券交易所网站披露 了公司《2025 年半年度报告》。为了便于广大投资者全面、深入了解公司 2025 年半年度经营成果及财务状况，公司计划于 2025 年 10 月 21 日下午 14:00 至 15:00 召开"2025 年半年度业绩说明会"，就投资者普遍关注的问题进行回答。 一、说明会类型 成果及财务指标的具体情况与投资者进行互动交流和沟通，在信息披露允许的范 围内就投资者普遍关注的问题进行回答。 二、说明会召开的时间、地点 1、会议召开时间：2025 年 10 月 21 日（星期二）下午 14:00-15:00 2、会议召开地点：上海证券交易所上证路演中心（网址： https://ro ...

Core Insights - The company reported a total revenue of 1.399 billion yuan for the first half of 2025, a decrease of 6.49% year-on-year, while the net profit attributable to shareholders was 2.6087 million yuan, an increase of 105.9% [1] - The second quarter revenue was 711 million yuan, down 8.64% year-on-year, but the net profit for the same period was 9.3266 million yuan, up 154.26% [1] - The company's profitability improved, with a gross margin increase of 33.34% and a net margin increase of 111.72% compared to the previous year [1] Financial Performance - Total revenue for 2024 was 1.496 billion yuan, while for 2025 it was 1.399 billion yuan, reflecting a decline of 6.49% [1] - The net profit for 2024 was a loss of 44.2223 million yuan, while for 2025 it turned into a profit of 2.6087 million yuan, marking a significant turnaround [1] - The gross margin for 2025 was 12.68%, up from 9.51% in 2024, and the net margin improved from -2.77% to 0.32% [1] Cost and Expenses - Total selling, administrative, and financial expenses amounted to 101 million yuan, accounting for 7.23% of revenue, which is an increase of 13.14% year-on-year [1] - The company's cash flow per share was -0.28 yuan, showing a 31.15% improvement from -0.4 yuan in the previous year [1] Asset and Liabilities - Cash and cash equivalents decreased by 52.28% from 932 million yuan in 2024 to 445 million yuan in 2025 [1] - Interest-bearing liabilities decreased by 29.36% from 775 million yuan to 547.1 million yuan [1] Business Model and Strategy - The company's performance is primarily driven by research and development, indicating a need for further analysis of the underlying factors supporting this growth [2]